Most Read This Week
- Final Note From the Metastatic Breast Cancer Editors
- Invasive Disease–Free Survival and Brain Metastasis Rates in Patients Treated With Neoadjuvant Chemotherapy With Trastuzumab and Pertuzumab
- Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease
- CYP2D6 Activity in Patients With Metastatic Breast Cancer Treated With Single-Agent Tamoxifen
- Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Patients With Metastatic Breast Cancer
Recently Updated
- Final Note From the Metastatic Breast Cancer Editors
- Invasive Disease–Free Survival and Brain Metastasis Rates in Patients Treated With Neoadjuvant Chemotherapy With Trastuzumab and Pertuzumab
- Assessing the Real-World Effectiveness of Eight Major Metastatic Breast Cancer Drugs Using Target Trial Emulation
- Impact of Molecular Tumor Board Recommendations on Clinical Outcomes in Patients With Metastatic Breast Cancer
- CYP2D6 Activity in Patients With Metastatic Breast Cancer Treated With Single-Agent Tamoxifen